James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 3,000 shares at $66.03 ($201K) on 2019-01-08, disclosed to the SEC on 2019-01-09.
Open-market sale of $201k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.03 | 800 | $53K | 26.3% |
| 2 | $66.82 | 1,000 | $67K | 33.2% |
| 3 | $67.95 | 1,200 | $82K | 40.5% |
| Total | $67.06 avg | 3,000 | $201K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |